Over the last few years, several groups have evaluated the potential of microRNAs
(miRNAs) as biomarkers for cardiometabolic disease. In this review, we discuss the …

Anucleate platelets, long viewed as merely cell fragments with a limited repertoire of rapid-
acting hemostatic functions, are now recognized to have a complex and dynamic …

Objective Heightened inflammation, dysregulated immunity, and thrombotic events are
characteristic of hospitalized COVID‐19 patients. Given that platelets are key regulators of …

Intravascular neutrophils and platelets collaborate in maintaining host integrity, but their
interaction can also trigger thrombotic complications. We report here that cooperation …

Abstract So‐called “reticulated” or “immature platelets,” which are newly released into the
circulation, are more reactive than mature platelets, contain more RNA, and can be counted …

The effect and clinical benefit of P2Y12 receptor antagonists may not be limited to platelet
inhibition and the prevention of arterial thrombus formation. Potential additional effects …

Lower-than-normal platelet counts are a hallmark of the acquired autoimmune illness known
as immune thrombocytopenia, which can affect both adults and children. Immune …

Reticulated platelets (RPs) are larger, hyperreactive platelets that contain significantly more
ribonucleic acid (RNA) compared with mature platelets (MPs). High levels of RPs in …

Human platelets differ considerably with regard to their size, RNA content and
thrombogenicity. Reticulated platelets (RPs) are young, hyper-reactive platelets that are …

Background Reticulated platelets (RP) are the youngest circulating platelets in blood. An
increased amount of this subpopulation is associated with higher cardiovascular risk and …